Recombinant
RabMAb

Anti-CD105 antibody [EPR10145-12] (ab169545)

Publishing research using ab169545? Please let us know so that we can cite the reference in this datasheet.

ab169545 has been referenced in 6 publications.

  • Fang M  et al. The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and a-SMA. Oncol Lett 15:4805-4812 (2018). PubMed: 29552120
  • Gerisch M  et al. Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy. Front Genet 9:72 (2018). PubMed: 29559994
  • Lund K  et al. 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin. J Exp Clin Cancer Res 36:187 (2017). PubMed: 29258566
  • Hu J  et al. Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells. Stem Cell Reports 9:464-477 (2017). PubMed: 28793246
  • Jiang S  et al. Co-evolution of tumor-associated macrophages and tumor neo-vessels during cervical cancer invasion. Oncol Lett 12:2625-2631 (2016). ICC ; Human . PubMed: 27698836
  • Hong CS  et al. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS One 9:e103310 (2014). WB ; Human . PubMed: 25093329

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up